Atopic dermatitis (AD) is a debilitating disease that disproportionately affects infants and young children and is considered the first step of the atopic march-the age-related progression of allergic disease.Consequently, there is an urgent unmet need to elucidate the root causes of AD and evaluate potential prevention mechanisms.Anecdotal evidence suggests that cow milk avoidance and substitution with other mammalian milk sources, such as goat milk (GM), has the potential to ameliorate AD symptoms.In this study, we assessed the therapeutic benefit of GM in AD in the absence of cow milk allergy and present a set of data suggesting that the noticeable therapeutic activity of GM against AD is mediated through the sensing of GM-derived lipids by NK T (NKT) cells and the effects of it on NKT cell-dependent recruitment of inflammatory eosinophils.To determine whether the consumption of GM infant formula (GMF) can decrease AD disease severity, we used a previously described MC903-driven model of AD-like disease.All strains of mice were housed under specific pathogen-free condition at the Malaghan Institute of Medical Research (Wellington, New Zealand).We compared GMF with two other GM products with contrasting lipid contents, i.e., reconstituted whole-GM powder (29.5% milk fat in dry matter) and skim GM powder (1% milk fat in dry matter).Consistent with a lipid-mediated mode of action, GMF (26% total fat, 13% milk fat in dry matter) and whole-GM powder had a similar effect on disease progression, whereas skim GM powder had no detectable activity.Because the lipid- and CD1-dependent reduction in disease severity may have been mediated by either type 1 (invariant) or type 2 NKT cells, we compared Cd1-/- mice, which are deficient in both types of NKT cells, with mice lacking the invariant NKT (iNKT) cell receptor a -chain gene segment TRAJ18 ( Ja 18-/-), which express CD1 but lack iNKT cells.Together, these results suggest that consumption of full-fat GM products can have a beneficial effect on AD disease severity, possibly by restraining iNKT cell-dependent eosinophilia.However, because the MC903 AD- like model is conducted in the absence of allergen, the therapeutic effect of dietary NKT-cell modulation in disease settings comprising allergen-specific T helper 2 cells and/or addnl. alarmins (e.g., IL-33) remains to be determinedFinally, further research is warranted to appropriately compare GM with cow and human milk and determine the interspecies variations in milk-derived NKT cell modulators.